文献速递心脑血管急症重症综合管理与镇静镇痛

远程神经重症监护用于大血管闭塞性缺血性卒中取栓患者

Teleneurocritical Care for Patients with Large Vessel Occlusive Ischemic Stroke Treated by Thrombectomy.
PubMed 文献 · Neurocrit Care · 2022-11-02
一句话结论多中心回顾性队列显示,取栓后大血管闭塞性缺血性卒中患者接受远程神经重症监护与面对面神经重症监护的出院时良好功能结局相似(31.4% vs 33.5%,OR 0.88,95%CI 0.6-1.3;p=0.64)。

该多中心回顾性队列纳入2018至2021年美国一家整合非营利医疗系统远程医疗网络内连续≥18岁、因大血管闭塞急性缺血性卒中接受取栓的患者437例,其中面对面神经重症监护医院226例、两家远程神经重症监护(TNCC)医院211例。主要终点出院时良好功能结局(改良Rankin量表0-3分)在两组相似(面对面31.4% vs TNCC 33.5%,OR 0.88,95%CI 0.6-1.3;p=0.64)。死亡(9.3% vs 13.2%,p=0.19)、ICU住院时长(2.1 vs 1.9天,p=0.39)、症状性颅内出血(6.8% vs 6.6%,p=0.47)均无差异。作者认为TNCC可提供与面对面神经重症监护等效的有利功能结局,本研究中TNCC使用的标准化方案可能对其他面对面资源有限的医疗系统有参考价值,但需进一步研究。

要点

  • 取栓后大血管闭塞性缺血性卒中患者出院时良好功能结局(mRS 0-3分):面对面神经重症监护31.4% vs TNCC 33.5%,OR 0.88(95%CI 0.6-1.3),p=0.64。
  • 死亡(9.3% vs 13.2%,p=0.19)、ICU住院时长(2.1 vs 1.9天,p=0.39)、症状性颅内出血(6.8% vs 6.6%,p=0.47)在面对面与TNCC之间均无差异。
  • 成功血管内治疗(mTICI 2b-3级)率在各医院间无差异。
  • 多因素分析中仅美国国立卫生研究院卒中量表评分和年龄是结局的预测因素。
  • 作者认为TNCC可为取栓后大血管闭塞性缺血性卒中患者提供与面对面神经重症监护等效的有利功能结局;本研究中TNCC使用的标准化方案(包括ICU住院期间全程24/7综合治疗)可能对其他面对面资源有限的医疗系统有参考价值,但需进一步研究。

适用人群与场景

  • ≥18岁、大血管闭塞急性缺血性卒中并接受取栓的连续患者,来自2018至2021年美国一家整合非营利医疗系统远程医疗网络内的多中心回顾性队列。
  • 面对面神经重症监护医院226例(中位年龄67岁,53%女性);两家TNCC医院211例(中位年龄74岁,49%女性)。

研究设计与关键结果

  • 多中心回顾性队列,共437例纳入,面对面神经重症监护医院226例、两家TNCC医院211例。
  • 主要终点出院时良好功能结局(改良Rankin量表0-3分):面对面31.4% vs TNCC 33.5%,OR 0.88(95%CI 0.6-1.3),p=0.64。
  • 成功血管内治疗(mTICI 2b-3级)率在各医院间无差异。
  • 死亡:面对面9.3% vs TNCC 13.2%,p=0.19;ICU住院时长:面对面2.1天 vs TNCC 1.9天,p=0.39;症状性颅内出血:面对面6.8% vs TNCC 6.6%,p=0.47。
  • 多因素分析中仅美国国立卫生研究院卒中量表评分和年龄是结局的预测因素。

证据类型、等级与局限

  • 证据类型:多中心回顾性队列研究。
  • 局限:需进一步研究(原文:additional study is required)。

对床旁实践的改变

  • 作者认为,对于接受取栓的急性大血管闭塞性缺血性卒中患者,TNCC可实现与面对面神经重症监护等效的有利功能结局。
  • 作者认为,本研究中TNCC使用的标准化方案,特别是ICU住院期间全程24/7综合治疗,可能对其他面对面资源有限的医疗系统有参考价值;但需进一步研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Teleneurocritical care (TNCC) provides 24/7 virtual treatment of patients with neurological disease in the emergency department or intensive care unit. However, it is not known if TNCC is safe, effective, or associated with similar outcomes compared with in-person neurocritical care. We aim to determine the effect of daily inpatient consults from TNCC on the outcomes of patients with large vessel occlusive acute ischemic stroke treated by thrombectomy.

METHODS: A multicenter, retrospective cohort of consecutive patients ≥ 18 years old with acute ischemic stroke from a large vessel occlusion treated by thrombectomy were identified from 2018 to 2021 within a telehealth network of an integrated not-for-profit health care system in the United States. The primary end point was good functional outcome, i.e., modified Rankin Scale 0-3, at the time of hospital discharge in patients receiving in-person neurocritical care versus TNCC.

RESULTS: A total of 437 patients met inclusion criteria, 226 at the in-person hospital (median age 67, 53% women) and 211 at the two TNCC hospitals (median age 74, 49% women). The rate of successful endovascular therapy (modified Thrombolysis in Cerebral Infarction score 2b-3) was not different among hospitals. Good functional outcome at discharge was similar between in-person neurocritical care and TNCC (in-person 31.4% vs. TNCC 33.5%, odds ratio 0.88, 95% confidence interval 0.6-1.3; p = 0.64). Only National Institutes of Health stroke scale and age were multivariable predictors of outcome. There were no differences in mortality (9.3% vs. 13.2%, p = 0.19), intensive care unit length of stay (2.1 vs. 1.9 days, p = 0.39), or rate of symptomatic intracerebral hemorrhage (6.8% vs. 6.6%, p = 0.47) between in-person neurocritical care and TNCC.

CONCLUSIONS: Teleneurocritical care allows for equivalent favorable functional outcomes compared with in-person neurocritical care for patients with acute large vessel ischemic stroke receiving thrombectomy. The standardized protocols used by TNCC in this study, specifically the comprehensive 24/7 treatment of patients in the intensive care unit for the length of their stay, may be relevant for other health systems with limited in-person resources; however, additional study is required.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Murray NM, Marshall S, Hoesch R, et al. Teleneurocritical Care for Patients with Large Vessel Occlusive Ischemic Stroke Treated by Thrombectomy. Neurocrit Care. 2022. PMID: 36324004. doi:10.1007/s12028-022-01632-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。